Rheumatoid Arthritis Drug Abatacept May Also Prevent the Disease
Rheumatoid arthritis drug abatacept, already used to treat the disease, may also prevent its onset, new research shows. Clinical trial results published in The Lancet indicate that abatacept eases symptoms and prevents joint damage, offering hope to the 1.3 million Americans living with the painful inflammatory disease.
University of Auckland researchers testing castor oil as potential treatment for dry-eye disease
University of Auckland researchers are testing the application of castor oil to treat dry-eye disease with promising results so far. The trial of castor oil as a potential safe and natural treatment for dry-eye disease is being conducted following a successful pilot study. With dry-eye disease affecting a significant portion of the population, the current trial aims to provide a long-term solution for patients grappling with uncomfortable symptoms. The use of cold-pressed castor oil in a unique application on the eyelids has shown measurable improvements in symptoms, leading to a more extensive study to generate robust scientific evidence for clinicians.
Gilead stock falls 10% after disappointing lung cancer drug trial results
Shares of Gilead took a hit as the stock fell more than 10% on Monday following disappointing results from a late-stage trial of its key lung cancer drug, Trodelvy. The trial failed to significantly extend the lives of patients with…